BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26707217)

  • 1. Novel vaccine antigen combinations elicit protective immune responses against Escherichia coli sepsis.
    Mellata M; Mitchell NM; Schödel F; Curtiss R; Pier GB
    Vaccine; 2016 Jan; 34(5):656-662. PubMed ID: 26707217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli.
    Lu X; Skurnik D; Pozzi C; Roux D; Cywes-Bentley C; Ritchie JM; Munera D; Gening ML; Tsvetkov YE; Nifantiev NE; Waldor MK; Pier GB
    mBio; 2014 Mar; 5(2):e00974-14. PubMed ID: 24667709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli.
    Durant L; Metais A; Soulama-Mouze C; Genevard JM; Nassif X; Escaich S
    Infect Immun; 2007 Apr; 75(4):1916-25. PubMed ID: 17145948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with the MipA, Skp, or ETEC_2479 Antigens Confers Protection against Enterotoxigenic
    Hays MP; Kumar A; Martinez-Becerra FJ; Hardwidge PR
    Front Cell Infect Microbiol; 2016; 6():181. PubMed ID: 28018863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.
    Luiz WB; Rodrigues JF; Crabb JH; Savarino SJ; Ferreira LC
    Infect Immun; 2015 Dec; 83(12):4555-64. PubMed ID: 26371126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Recombinant Attenuated
    Maddux JT; Stromberg ZR; Curtiss Iii R; Mellata M
    Front Immunol; 2017; 8():1280. PubMed ID: 29062318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed mucosal-parenteral immunizations with the broadly conserved pathogenic Escherichia coli antigen SslE induce a robust mucosal and systemic immunity without affecting the murine intestinal microbiota.
    Naili I; Vinot J; Baudner BC; Bernalier-Donadille A; Pizza M; Desvaux M; Jubelin G; D'Oro U; Buonsanti C
    Vaccine; 2019 Jan; 37(2):314-324. PubMed ID: 30503655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens.
    Gening ML; Maira-Litrán T; Kropec A; Skurnik D; Grout M; Tsvetkov YE; Nifantiev NE; Pier GB
    Infect Immun; 2010 Feb; 78(2):764-72. PubMed ID: 19948836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First multi-epitope subunit vaccine against extraintestinal pathogenic Escherichia coli delivered by a bacterial type-3 secretion system (T3SS).
    Wieser A; Magistro G; Nörenberg D; Hoffmann C; Schubert S
    Int J Med Microbiol; 2012 Jan; 302(1):10-8. PubMed ID: 22000741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.
    Maira-Litrán T; Kropec A; Goldmann DA; Pier GB
    Infect Immun; 2005 Oct; 73(10):6752-62. PubMed ID: 16177353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic characterization of outer membrane porins OmpC and OmpF of porcine extraintestinal pathogenic Escherichia coli.
    Liu C; Chen Z; Tan C; Liu W; Xu Z; Zhou R; Chen H
    FEMS Microbiol Lett; 2012 Dec; 337(2):104-11. PubMed ID: 23003111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
    Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
    Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with outer membrane vesicles displaying conserved surface polysaccharide antigen elicits broadly antimicrobial antibodies.
    Stevenson TC; Cywes-Bentley C; Moeller TD; Weyant KB; Putnam D; Chang YF; Jones BD; Pier GB; DeLisa MP
    Proc Natl Acad Sci U S A; 2018 Apr; 115(14):E3106-E3115. PubMed ID: 29555731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capsular polysaccharide and the O-specific antigen impede antibody binding: a potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine.
    Russo TA; Beanan JM; Olson R; MacDonald U; Cope JJ
    Vaccine; 2009 Jan; 27(3):388-95. PubMed ID: 19014988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice.
    Lin R; Zhu B; Zhang Y; Bai Y; Zhi F; Long B; Li Y; Wu Y; Wu X; Fan H
    Microb Pathog; 2017 Apr; 105():19-24. PubMed ID: 28163157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice.
    Wieser A; Romann E; Magistro G; Hoffmann C; Nörenberg D; Weinert K; Schubert S
    Infect Immun; 2010 Aug; 78(8):3432-42. PubMed ID: 20498257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria.
    Tobias J; Holmgren J; Hellman M; Nygren E; Lebens M; Svennerholm AM
    Vaccine; 2010 Oct; 28(43):6977-84. PubMed ID: 20728524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunization with iron receptor antigens protects against urinary tract infection.
    Alteri CJ; Hagan EC; Sivick KE; Smith SN; Mobley HL
    PLoS Pathog; 2009 Sep; 5(9):e1000586. PubMed ID: 19806177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.